Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026)

Emergent BioSolutions (EBS) posted Asset Utilization Ratio of 0.63 for Q2 2026, up 23.22% on a QoQ basis from 0.51 in Q1 2026, and up 5.51% year-over-year from 0.6 in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Emergent BioSolutions has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.63 in Q2 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 5.51% year-over-year to 0.63 in Q2 2026; TTM through Jun 2026 was 0.63, a 5.51% increase from a year earlier, with the FY2025 full-year figure at 0.55, down 15.55% from the prior year.
  • Asset Utilization Ratio was 0.63 for Q2 2026 at Emergent BioSolutions, up from 0.51 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.75 in Q3 2024, with the low at 0.32 in Q1 2023.
  • Average Asset Utilization Ratio over 5 years is 0.57, with a median of 0.57 recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio plunged 46.13% in 2023, then surged 104.61% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.37 in 2022, then jumped by 53.16% to 0.56 in 2023, then climbed by 28.9% to 0.73 in 2024, then slipped by 26.56% to 0.53 in 2025, then rose by 18.24% to 0.63 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.63 (Q2 2026), 0.51 (Q1 2026), and 0.53 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 0.49
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 0.47
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 0.52
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 0.57
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 0.31
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 0.56
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 0.36
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 0.69
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 0.63
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.63
Mar 31, 2026 0.51
Dec 31, 2025 0.53
Sep 30, 2025 0.55
Jun 30, 2025 0.60
Mar 31, 2025 0.69
Dec 31, 2024 0.73
Sep 30, 2024 0.75
Jun 30, 2024 0.66
Mar 31, 2024 0.65
Dec 31, 2023 0.56
Sep 30, 2023 0.54
Jun 30, 2023 0.42
Mar 31, 2023 0.32
Dec 31, 2022 0.37
Sep 30, 2022 0.54
Jun 30, 2022 0.57
Mar 31, 2022 0.59
Dec 31, 2021 0.61
Sep 30, 2021 0.56
API Access

Emergent BioSolutions Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EBS&period=max&api_key=YOUR_API_KEY